You just read:

Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019

News provided by

Eiger BioPharmaceuticals, Inc.

Nov 12, 2019, 08:45 ET